Company: REVB
Filing Date: 2025-05-29
Form Type: PRE 14A
Source: 0000950170-25-078948
Chunk: 54

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-05-29
Form: PRE 14A
Chunk 54
---
 Company for audit and other services provided by Baker Tilly US, LLP for the years ended years ended December 31, 2024 and 2023.

|               |     | Year Ended   
 December 31, |    2024 |     |   |    2023 |
|:--------------|:----|:-------------|--------:|:----|:--|--------:|
| Audit Fees(a) |     | $            | 404,568 |     | $ | 292,833 |
| Tax Fees(b)   |     |              |  15,900 |     |   |  29,203 |
| Other Fees(c) |     |              |       - |     |   |       - |
| Total         |     | $            | 420,468 |     | $ | 322,036 |

____________ (a) Audit fees represent fees for professional services provided in connection with the audit of the Company’s annual financial statements and the review of its financial statements included in the Company’s Quarterly Reports on Form 10-Q and services that are normally provided in connection with statutory or regulatory filings. (b) Tax fees represent fees for professional services related to tax compliance, tax advice and tax planning. (c) Other fees represent fees related to our filing of certain Registration Statements. Pre-Approval Policies and Procedures All audit related services, tax services and other services rendered by Baker Tilly US, LLP were pre-approved by the Company’s Board of Directors. Commencing in 2020, the Audit Committee was charged with all pre-approval activities with respect to the Company’s independent registered public accounting firm. The Audit Committee has adopted a pre-approval policy that provides for the pre-approval of all services performed for the Company by its independent registered public accounting firm. Our independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval policy, and the fees for the services performed to date. Report of the Audit Committee The Audit Committee oversees our financial reporting process. Management has the primary responsibility for the consolidated financial statements and the reporting process, including our system of internal control over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviewed and discussed the audited consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2024 with management, including a discussion of the quality, not merely the acceptability, of the accounting